Cite
HARVARD Citation
Cohen Aubart, F. et al. (2018). Efficacy of the MEK inhibitor cobimetinib for wild‐type BRAF Erdheim‐Chester disease. British journal of haematology. pp. 150-153. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Cohen Aubart, F. et al. (2018). Efficacy of the MEK inhibitor cobimetinib for wild‐type BRAF Erdheim‐Chester disease. British journal of haematology. pp. 150-153. [Online].